SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001140361-17-027803
Filing Date
2017-07-13
Accepted
2017-07-13 17:00:15
Documents
2
Period of Report
2017-07-11

Document Format Files

Seq Description Document Type Size
1 FORM 4 doc1.html 4  
1 FORM 4 doc1.xml 4 13651
2 EXPLANATION OF RESPONSES g21538301.htm EX-99.1 5982
  Complete submission text file 0001140361-17-027803.txt   22170
Mailing Address 300 PARK AVENUE 21ST FLOOR NEW YORK NY 10022
Business Address 300 PARK AVENUE 21ST FLOOR NEW YORK NY 10022 2128473500
GOLDENTREE ASSET MANAGEMENT LP (Reporting) CIK: 0001278951 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-37841 | Film No.: 17964002

Mailing Address 300 PARK AVENUE 21ST FLOOR NEW YORK NY 10022
Business Address
Tananbaum Steven A. (Reporting) CIK: 0001435626 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37841 | Film No.: 17964000

Mailing Address 300 PARK AVENUE 21ST FLOOR NEW YORK NY 10022
Business Address 300 PARK AVENUE 21ST FLOOR NEW YORK NY 10022 212-847-3500
GoldenTree Asset Management LLC (Reporting) CIK: 0001435627 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-37841 | Film No.: 17964001

Mailing Address 450 EAST 29TH STREET NEW YORK NY 10016
Business Address 450 EAST 29TH STREET NEW YORK NY 10016 212-308-6000
Kadmon Holdings, Inc. (Issuer) CIK: 0001557142 (see all company filings)

IRS No.: 273576929 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations